Solugen

the Bioforge runs a chemienzymatic route — computationally engineered enzymes paired with metal catalysis — converting plant-derived sugars into organic acids and other building blocks that displace petrochemical feedstocks; a strategic partnership with ADM sites a production facility next to ADM's Marshall,…

Country
United States
Commercial
Coverage
CNEUINUS
enzymes-biocatalysis✓✓✓✓
Regulatorsepareachmoa-china

Verifiable facts

FactValueSource
Fundingover $850 million in equity and debt financing as of March 2025research.contrary.com
Funding$213.6 million conditional loan guarantee from the U.S. Department of Energy (June 2024)research.contrary.com · linqto.com · prnewswire.com
Capacityup to 120 kilotonnes per annum (KTA) at Bioforge Marshall; 10 kilotonnes per annum (KTA) at Houston facilityresearch.contrary.com · solugen.com · energy.gov · prnewswire.com
CertificationISO 9001; CMMC Level 2 Readybuiltin.com · solugen.com · wayup.com
Regulatory approvalCompliant with federal, state, and international requirements including FIFRA, DOT, TSCA, and OSHA GHSbuiltin.com · pac.org
Production siteBioforge Houston, Texas (operational); Bioforge Marshall, Minnesota (under construction, operational by fall 2025); Slaton, Texas facilitycen.acs.org · research.contrary.com · solugen.com
Headcount137 employees as of April 2025research.contrary.com
Revenueon pace for over $100 million in revenue in 2022research.contrary.com · linqto.com

Independent sources: builtin.com · cen.acs.org · energy.gov · linqto.com · pac.org · prnewswire.com · research.contrary.com · wayup.com

Technologies
NameClusterRisk
Biocatalysis in petrochemistryenzymes-biocatalysisLow→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.